Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Imlygic'
Latest

FDA OKs Amgen skin cancer drug Imlygic

By   /  Tuesday, October 27th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on FDA OKs Amgen skin cancer drug Imlygic

The U.S. Food and Drug Administration on Oct. 27 approved Amgen’s cancer immunotherapy drug Imlygic for use in patients with the most deadly types of skin cancer. Imlygic, which is the first immunotherapy like this to gain approval for use in the U.S., is a genetically modified herpes virus that is designed to replicate itself Read More →

Read More →